P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
AXLA | N/A | N/A | N/A | +4.76% |
AXLA Peer | N/A | N/A | N/A | -127.39% |
Biotechnology Industry | 18.0 | 16.3 | 0.3 | +53.28% |
Health Technology Sector | 32.9 | 21.4 | 0.5 | +26.68% |
S&P 500 Market | 32.3 | 27.3 | 1.1 | +98.98% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.39 | -$0.38 | -$0.37 | -$0.40 |
Previous Mean | -$0.36 | -$0.38 | N/A | N/A |
Standard Deviation | 0.05 | 0.06 | 0.07 | 0.01 |
Low Estimate | -$0.47 | -$0.48 | -$0.49 | -$0.40 |
High Estimate | -$0.35 | -$0.30 | -$0.26 | -$0.39 |